Related references
Note: Only part of the references are listed.What role can decentralized trial designs play to improve rare disease studies?
J. Moore et al.
ORPHANET JOURNAL OF RARE DISEASES (2022)
Stakeholder perspectives on clinical research related to therapies for rare diseases: therapeutic misconception and the value of research
Kylie Tingley et al.
ORPHANET JOURNAL OF RARE DISEASES (2021)
Sustaining Meaningful Patient Engagement Across the Lifecycle of Medicines: A Roadmap for Action
Maria Cavaller-Bellaubi et al.
THERAPEUTIC INNOVATION & REGULATORY SCIENCE (2021)
Patient Engagement Initiatives in Clinical Trials: Recent Trends and Implications
Shalome Sine et al.
THERAPEUTIC INNOVATION & REGULATORY SCIENCE (2021)
Pricing of pharmaceuticals is becoming a major challenge for health systems
Steven Morgan et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
A Novel Collaborative Approach to Building Better Clinical Trials: New Insights From a Patient Engagement Workshop to Propel Patient-Centricity Forward
Alyson Gregg et al.
THERAPEUTIC INNOVATION & REGULATORY SCIENCE (2020)
Experiences of caregivers of children with spinal muscular atrophy participating in the expanded access program for nusinersen: a longitudinal qualitative study
Petra Kiefer et al.
ORPHANET JOURNAL OF RARE DISEASES (2020)
To what degree are orphan drugs patient-centered? A review of the current state of clinical research in rare diseases
Sally Lanar et al.
ORPHANET JOURNAL OF RARE DISEASES (2020)
Developing a roadmap to improve trial delivery for under-served groups: results from a UK multi-stakeholder process
Miles D. Witham et al.
TRIALS (2020)
The urgent need to empower rare disease organizations in China: an interview-based study
Xuefeng Li et al.
ORPHANET JOURNAL OF RARE DISEASES (2020)
Improving reporting of meta-ethnography: the eMERGe reporting guidance
Emma F. France et al.
BMC MEDICAL RESEARCH METHODOLOGY (2019)
The patient's view on rare disease trial design - a qualitative study
C. M. W. Gaasterland et al.
ORPHANET JOURNAL OF RARE DISEASES (2019)
Frameworks for supporting patient and public involvement in research: Systematic review and co-design pilot
Trisha Greenhalgh et al.
HEALTH EXPECTATIONS (2019)
'Engagement' of patients and healthcare professionals in regulatory pharmacovigilance: establishing a conceptual and methodological framework
Patrick Brown et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2019)
'Wicked problems', community engagement and the need for an implementation science for research ethics
James V. Lavery
JOURNAL OF MEDICAL ETHICS (2018)
Beyond Consent: Building Trusting Relationships With Diverse Populations in Precision Medicine Research
Stephanie A. Kraft et al.
AMERICAN JOURNAL OF BIOETHICS (2018)
Patient understanding of, satisfaction with, and perceived utility of whole-genome sequencing: findings from the MedSeq Project
J. Scott Roberts et al.
GENETICS IN MEDICINE (2018)
Using a meta-narrative literature review and focus groups with key stakeholders to identify perceived challenges and solutions for generating robust evidence on the effectiveness of treatments for rare diseases
Kylie Tingley et al.
ORPHANET JOURNAL OF RARE DISEASES (2018)
The POWER-tool: Recommendations for involving patient representatives in choosing relevant outcome measures during rare disease clinical trial design
C. M. W. Gaasterland et al.
HEALTH POLICY (2018)
Engagement of Canadian Patients with Rare Diseases and Their Families in the Lifecycle of Therapy: A Qualitative Study
Andrea Young et al.
PATIENT-PATIENT CENTERED OUTCOMES RESEARCH (2018)
Chasing cures: Rewards and risks for rare disease patient organisations involved in research
Deirdre Pinto et al.
BIOSOCIETIES (2018)
Patient Voice in Rare Disease Drug Development and Endpoints
Linda S. Deal et al.
THERAPEUTIC INNOVATION & REGULATORY SCIENCE (2017)
Exploring patient and family involvement in the lifecycle of an orphan drug: a scoping review
Andrea Young et al.
ORPHANET JOURNAL OF RARE DISEASES (2017)
GRIPP2 reporting checklists: tools to improve reporting of patient and public involvement in research
S. Staniszewska et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
GRIPP2 reporting checklists: tools to improve reporting of patient and public involvement in research
S. Staniszewska et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
Patient Centricity and Pharmaceutical Companies: Is It Feasible?
Danie du Plessis et al.
THERAPEUTIC INNOVATION & REGULATORY SCIENCE (2017)
Improving Patient Involvement in Medicines Research and Development:: A Practical Roadmap
Jan Geissler et al.
THERAPEUTIC INNOVATION & REGULATORY SCIENCE (2017)
Development and testing of a medline search filter for identifying patient and public involvement in health research
Morwenna Rogers et al.
HEALTH INFORMATION AND LIBRARIES JOURNAL (2017)
Engaging Participants in Rare Disease Research: A Qualitative Study of Duchenne Muscular Dystrophy
Roxanna M. Bendixen et al.
CLINICAL THERAPEUTICS (2016)
Sample Size in Qualitative Interview Studies: Guided by Information Power
Kirsti Malterud et al.
QUALITATIVE HEALTH RESEARCH (2016)
Taxonomy of the burden of treatment: a multi-country web-based qualitative study of patients with chronic conditions
Viet-Thi Tran et al.
BMC MEDICINE (2015)
Now I see it, now I don't: researcher's position and reflexivity in qualitative research
Roni Berger
QUALITATIVE RESEARCH (2015)
Developing a Patient-Directed Policy Framework for Managing Orphan and Ultra-Orphan Drugs Throughout Their Lifecycle
Devidas Menon et al.
PATIENT-PATIENT CENTERED OUTCOMES RESEARCH (2015)
Development and Use of New Therapeutics for Rare Diseases: Views from Patients, Caregivers, and Advocates
Aaron S. Kesselheim et al.
PATIENT-PATIENT CENTERED OUTCOMES RESEARCH (2015)
Meta-ethnography 25 years on: challenges and insights for synthesising a large number of qualitative studies
Francine Toye et al.
BMC MEDICAL RESEARCH METHODOLOGY (2014)
Expectations and experiences of investigators and parents involved in a clinical trial for Duchenne/Becker muscular dystrophy
Holly L. Peay et al.
CLINICAL TRIALS (2014)
The voluntary sector and health policy: The role of national level health consumer and patients' organisations in the UK
Rob Baggott et al.
SOCIAL SCIENCE & MEDICINE (2014)
I Want You to Save My Kid!: Illness Management Strategies, Access, and Inequality at an Elite University Research Hospital
Amanda M. Gengler
JOURNAL OF HEALTH AND SOCIAL BEHAVIOR (2014)
Motivations of patients with pulmonary arterial hypertension to participate in randomized clinical trials
Ricki Carroll et al.
CLINICAL TRIALS (2012)
Evaluating meta-ethnography: systematic analysis and synthesis of qualitative research
R. Campbell et al.
HEALTH TECHNOLOGY ASSESSMENT (2011)
Medication career or Moral career? The two sides of managing antidepressants: A meta-ethnography of patients' experience of antidepressants
Alice Malpass et al.
SOCIAL SCIENCE & MEDICINE (2009)
Who rules rare disease associations? A framework to understand their action
Caroline Huyard
SOCIOLOGY OF HEALTH & ILLNESS (2009)
How did uncommon disorders become 'rare diseases'? History of a boundary object
Caroline Huyard
SOCIOLOGY OF HEALTH & ILLNESS (2009)
A multidimensional conceptual framework for analysing public involvement in health services research
Sandy R. Oliver et al.
HEALTH EXPECTATIONS (2008)
Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups
Allison Tong et al.
INTERNATIONAL JOURNAL FOR QUALITY IN HEALTH CARE (2007)
Developing optimal search strategies for detecting clinically sound prognostic studies in MEDLINE: an analytic survey
Nancy L. Wilczynski et al.
BMC MEDICINE (2004)
Evaluating meta-ethnography: a synthesis of qualitative research on lay experiences of diabetes and diabetes care
R Campbell et al.
SOCIAL SCIENCE & MEDICINE (2003)
Share Paper
